4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016360
Options or other derivatives
- Director acquired 796,154 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Waksal Harlan · Director
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-11-17 | Grant or award : show line 1 in the form Common Stock Option | +96,154 | $0.26 | 2020-11-17 | 96,154 | 360,112 | D |
| 2010-11-17 | Grant or award : show line 2 in the form Common Stock Option | +200,000 | $0.26 | 2020-11-17 | 200,000 | 560,112 | D |
| 2010-11-17 | Grant or award : show line 3 in the form Common Stock Option | +500,000 | $0.26 | 2020-11-17 | 500,000 | 1,060,112 | D |
Loading xslF345X03/edgar.xml…